Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

(Pre)diabetes, brain aging, and cognition.

S Roriz-Filho J, Sá-Roriz TM, Rosset I, Camozzato AL, Santos AC, Chaves ML, Moriguti JC, Roriz-Cruz M.

Biochim Biophys Acta. 2009 May;1792(5):432-43. doi: 10.1016/j.bbadis.2008.12.003. Epub 2008 Dec 16. Review.

2.

[Dementia and diabetes mellitus].

Pavlović DM, Pavlović AM.

Srp Arh Celok Lek. 2008 Mar-Apr;136(3-4):170-5. Review. Serbian.

3.

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.

Chen Z, Zhong C.

Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11. Review.

4.

Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential.

Sato N, Takeda S, Uchio-Yamada K, Ueda H, Fujisawa T, Rakugi H, Morishita R.

Curr Aging Sci. 2011 Jul;4(2):118-27. Review.

PMID:
21235496
5.

Type 2 diabetes and risk of cognitive impairment and dementia.

Whitmer RA.

Curr Neurol Neurosci Rep. 2007 Sep;7(5):373-80. Review.

PMID:
17764626
6.

Insulin resistance in the brain: an old-age or new-age problem?

Williamson R, McNeilly A, Sutherland C.

Biochem Pharmacol. 2012 Sep 15;84(6):737-45. doi: 10.1016/j.bcp.2012.05.007. Epub 2012 May 16. Review.

PMID:
22634336
7.

Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.

Takeda S, Sato N, Rakugi H, Morishita R.

Mol Biosyst. 2011 Jun;7(6):1822-7. doi: 10.1039/c0mb00302f. Epub 2011 Mar 24. Review.

PMID:
21431241
8.

Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.

Qiu WQ, Folstein MF.

Neurobiol Aging. 2006 Feb;27(2):190-8. Epub 2005 Feb 17. Review.

PMID:
16399206
9.

Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.

de la Monte SM.

Drugs. 2012 Jan 1;72(1):49-66. doi: 10.2165/11597760-000000000-00000. Review.

10.

Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

Butterfield DA, Di Domenico F, Barone E.

Biochim Biophys Acta. 2014 Sep;1842(9):1693-706. doi: 10.1016/j.bbadis.2014.06.010. Epub 2014 Jun 17. Review.

11.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
12.

[Dementia and diabetes: casual or causal relationship?].

Formiga F, Reñe R, Pérez-Maraver M.

Med Clin (Barc). 2015 Feb 20;144(4):176-80. doi: 10.1016/j.medcli.2014.01.026. Epub 2014 Mar 13. Review. Spanish.

PMID:
24629693
13.

Diabetes mellitus and dementia.

Pasquier F, Boulogne A, Leys D, Fontaine P.

Diabetes Metab. 2006 Nov;32(5 Pt 1):403-14. Review.

PMID:
17110895
14.

Cognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist's perspective.

Simó R, Ciudin A, Simó-Servat O, Hernández C.

Acta Diabetol. 2017 May;54(5):417-424. doi: 10.1007/s00592-017-0970-5. Epub 2017 Feb 16. Review.

PMID:
28210868
15.

Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.

Takeuchi M, Yamagishi S.

Curr Pharm Des. 2008;14(10):973-8. Review.

PMID:
18473848
16.

Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?

Biessels GJ, Kappelle LJ; Utrecht Diabetic Encephalopathy Study Group.

Biochem Soc Trans. 2005 Nov;33(Pt 5):1041-4. Review.

PMID:
16246041
17.

Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome.

Kim B, Feldman EL.

Exp Mol Med. 2015 Mar 13;47:e149. doi: 10.1038/emm.2015.3. Review.

18.

Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.

Kang S, Lee YH, Lee JE.

Yonsei Med J. 2017 May;58(3):479-488. doi: 10.3349/ymj.2017.58.3.479. Review.

19.

Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.

Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, Vendemiale G, Pilotto A, Panza F.

Ageing Res Rev. 2010 Oct;9(4):399-417. doi: 10.1016/j.arr.2010.04.007. Epub 2010 May 2. Review.

PMID:
20444434
20.

Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.

Kimura N.

Int J Mol Sci. 2016 Apr 5;17(4):503. doi: 10.3390/ijms17040503. Review.

Supplemental Content

Support Center